Clinical Trial Update: Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating stem cell therapy in multiple sclerosis patients who failed other approved therapies; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Northwestern University | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12